Literature DB >> 7316728

[Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].

F Schumm, J Dichgans, E Zeller.   

Abstract

Tetrabenazine (50-150 mg/day) was a moderate to excellent efficacy in each of six patients with severe spontaneous oral dyskinesia. Slight akinesia, rigidity, and transient disorientation were occasional side effects that could easily be controlled and were tolerated by the patient in view of the lasting amelioration of this debilitating symptom. When tetrabenazine was administered for blepharospasm, only two of six cases showed partial improvement with more severe side effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7316728

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  2 in total

Review 1.  Do neuroleptic drugs still have a place in neurological therapy?

Authors:  T Klockgether; J Dichgans
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

2.  Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.

Authors:  M Bartels; E Zeller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.